Intensive Care National Audit & Research Centre
15
1
2
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
13%
2 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
A Study to Evaluate the Introduction of New Staffing Models in Intensive Care: a Realist Evaluation (SEISMIC-R)
Role: collaborator
Exploring Pulse OXimeter Accuracy Across SKin Tones
Role: lead
Oxy-PICU Neurodevelopmental Follow-up Study
Role: lead
Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales
Role: collaborator
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Role: collaborator
Treatment of Invasively Ventilated Adults With Early Activity and Mobilisation
Role: collaborator
Risk Modelling for Quality Improvement in the Critically Ill: Making Best Use of Routinely Available Data
Role: lead
Critical Illness Related Cardiac Arrest (CIRCA)
Role: lead
Statistical Analysis Plan for an Individual Patient Data Meta-analysis of Three, International Trials Comparing Protocolised With Usual Resuscitation in Patients Presenting to the Emergency Department With Severe Sepsis and Septic Shock
Role: collaborator
Renal Replacement Anticoagulant Management
Role: lead
Conservative Versus Liberal Oxygenation Targets in Critically Ill Children
Role: collaborator
Fever Observational Study
Role: lead
FIRST-line Support for Assistance in Breathing in Children (FIRST-ABC) Feasibility Study
Role: collaborator
Evaluation of the Association Between Day and Time of Admission to Critical Care and Acute Hospital Outcome
Role: lead
Sepsis Pathophysiological & Organisational Timing
Role: lead
All 15 trials loaded